Search Within

Christopher G Azzoli

  1. "Sarcoma Service"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (8)
  2. Hematologic Malignancies, Division of (8)
  3. Sarcoma Service (8)
  4. Solid Tumor Oncology Division (8)
  5. Thoracic Oncology (7)
  6. Surgery (6)

More Groups

People
  1. Sandra D'Angelo (8)
  2. Mark Kris (7)
  3. Bernard Park (5)
  4. Camelia Sima (3)
  5. Marc Ladanyi (3)
  6. Maureen Zakowski (3)

More People

Years
  1. 2014 (1)
  2. 2012 (1)
  3. 2011 (5)
  4. 2010 (1)
Publications
  1. Journal of Thoracic Oncology (4)
  2. Journal of Clinical Oncology (2)
  3. Clinical Lung Cancer (1)
  4. Journal of Thoracic and Cardiovascular Surgery (1)
Publishers
  1. Elsevier Inc. (5)
  2. American Society of Clinical Oncology (2)
  3. Mosby Elsevier (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation
    Journal Article

    Chaft, J. E.; Litvak, A.; Arcila, M. E.; Patel, P.; D'Angelo, S. P.; Krug, L. M.; Rusch, V.; Mattson, A.; Coeshott, C.; Park, B.; more...
    Clinical Lung Cancer (2014)

    Fulltext@MSK | Save
  • Distinct clinical course of EGFR-mutant resected lung cancers: Results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib
    Journal Article

    D'Angelo, S. P.; Janjigian, Y. Y.; Ahye, N.; Riely, G. J.; Chaft, J. E.; Sima, C. S.; Shen, R.; Zheng, J.; Dycoco, J.; Kris, M. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations
    Meeting Abstract

    D'Angelo, S. P.; Park, B. J.; Krug, L. M.; Crevar, C.; Medina, C. E.; Sumner, D. K.; Richman, J.; Coeshott, C.; Apelian, D.; Cohn, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A histological grading system has prognostic significance for patients with resected lung adenocarcinoma that received adjuvant chemotherapy
    Meeting Abstract

    D'Angelo, S. P.; Sima, C. S.; Azzoli, C. G.; Moreira, A. L.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations
    Journal Article

    Janjigian, Y. Y.; Park, B. J.; Zakowski, M. F.; Ladanyi, M.; Pao, W.; D'Angelo, S. P.; Kris, M. G.; Shen, R.; Zheng, J.; Azzoli, C. G.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed
    Journal Article

    D'Angelo, S. P.; Kris, M. G.; Pietanza, M. C.; Rizvi, N. A.; Azzoli, C. G.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Reflex testing of resected stage i through III lung adenocarcinomas for EGFR and KRAS mutation: Report on initial experience and clinical utility at a single center
    Journal Article

    D'Angelo, S. P.; Park, B.; Azzoli, C. G.; Kris, M. G.; Rusch, V.; Ladanyi, M.; Zakowski, M. F.
    Journal of Thoracic and Cardiovascular Surgery (2011)

    Fulltext@MSK | Save
  • Impact of EGFR and KRAS mutations on survival in 1,000 patients with resected lung adenocarcinoma
    Meeting Abstract

    D'Angelo, S. P.; Janjigian, Y. Y.; Kris, M. G.; Pao, W.; Riely, G. J.; Marks, J.; Sima, C.; Dycoco, J.; Park, B. J.; Azzoli, C. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save